Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
Ginkgo Bioworks Announces Participation In Upcoming Conferences Feb. 15 And 18
Ginkgo Bioworks (NYSE:DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the following upcoming conferences:
BTIG MedTech, Digital Health,
B of A Securities Initiates Coverage On Ginkgo Bioworks Holdings with Neutral Rating, Announces Price Target of $6
B of A Securities analyst Derik De Bruin initiates coverage on Ginkgo Bioworks Holdings (NYSE:DNA) with a Neutral rating and announces Price Target of $6.
Why BofA Sees ‘Better Entry Point’ In Ginkgo Bioworks Stock
Ginkgo Bioworks Holdings Inc (NYSE: DNA) is “at the forefront of the rising SynBio wave, a market we think holds much long-term promise,” according to BofA Securities.
B of A Securities Initiates Coverage On Ginkgo Bioworks Holdings with Buy Rating, Announces Price Target of $8
B of A Securities analyst Derik De Bruin initiates coverage on Ginkgo Bioworks Holdings (NYSE:DNA) with a Buy rating and announces Price Target of $8.
Why Ginkgo Bioworks Shares Are Trading Higher Today
Ginkgo Bioworks Holdings Inc (NYSE: DNA) is trading higher Wednesday after the company reported preliminary unaudited 2021 revenue highlights and a business review.
BTIG Initiates Coverage On Ginkgo Bioworks Holdings with Buy Rating, Announces Price Target of $12
BTIG analyst Mark Massaro initiates coverage on Ginkgo Bioworks Holdings (NYSE:DNA) with a Buy rating and announces Price Target of $12.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.